SCHEMBL16017403

SCHEMBL16017403

Cc1cc(F)c(C(=O)Nc2ccc(N(C)c3cc(F)ccc3C(F)(F)F)c(F)c2)c(F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
LMNA P02545 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
POLB P06746 1/20 0.37
SCN8A Q9UQD0 2/20 0.36
SCN10A Q9Y5Y9 2/20 0.36
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
PLAT P00750 1/20 0.36
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
KCNE1 P15382 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14887635 0.94 SMN1; SMN2 (0.39) HTTLMNASMN1; SMN2MAPTRAB9A
SCHEMBL16017404 0.93 HTT (0.46) HTTLMNASMN1; SMN2MAPTRAB9A
SCHEMBL14887638 0.90 RAB9A (0.46) HTTSMN1; SMN2MAPTRAB9AMEN1
SCHEMBL14887636 0.88 BUB1 (0.40) HTTLMNASMN1; SMN2MAPTPOLB
SCHEMBL16017395 0.88 SMN1; SMN2 (0.43) HTTLMNASMN1; SMN2MAPTRAB9A
SCHEMBL16017397 0.88 LMNA (0.46) HTTLMNASMN1; SMN2MAPTRAB9A
SCHEMBL14887639 0.87 RAB9A (0.41) HTTLMNASMN1; SMN2MAPTRAB9A
SCHEMBL14887643 0.86 SMN1; SMN2 (0.40) HTTLMNASMN1; SMN2MAPTRAB9A
SCHEMBL14887644 0.83 LMNA (0.51) HTTLMNASMN1; SMN2MAPTRAB9A
SCHEMBL14887630 0.83 GRM4 (0.41) HTTLMNASMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 HTT 809/4885LMNA 1306/4885SMN1; SMN2 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.